Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND

Journal of the Neurological Sciences

Volumn 139, Issue SUPPL., 1996, Pages 16-26

  Chou, Samuel M ^a   Wang, Helen S ^a   Taniguchi, Akira ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis Motor neuron disease; Citrulline; Cyclic GMP; Neurofilament; Nitric oxide synthase; Nitrotyrosine; Peroxynitrite; Superoxide dismutase 1

Indexed keywords

3 NITROTYROSINE; CALMODULIN; CITRULLINE; CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROFILAMENT; PRIORITY JOURNAL;

EID: 0029840369     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00090-1     Document Type: Conference Paper

References (59)

1. Borchelt, D.R., M. Guarnieri, P.C. Wong, M.K. Lee, H.S. Slunt, Z.S. Xu, S.S. Sisodia, D.L. Price and D.W. Cleveland (1995) Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J. Biol. Chem., 270: 3234-3238.
2. Beckman, J.S., J. Chen, J.P. Crow and Y.Z. Ye (1994) Reaction of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog. Brain Res., 103: 372-380.
3. Beckman, J.S., M. Carson, C.D. Smith and W.H. Koppenol (1993) ALS, SOD and peroxynitrite. Nature, 364: 584-585.
4. Carpenter, S. (1968) Proximal axonal enlargement in motor neuron disease. Neurology, 18: 841-851.
5. Chou, S.M. (1995) Pathology of Motor System Disorders. In: Leigh, N. and Swash, M. (Eds.), Motor Neuron Disease: Biology and Management. Springer, London, Chapter 4, pp. 84-140.
6. Chou, S.M. (1994) Accumulation of disassembled neurofilaments in upper motor neurons of amyotrophic lateral sclerosis. In: Rose, F.C. (Ed.), ALS - From Charcot to the Present and into the Future. Smith-Gordon, London, Chapter 22, pp. 167-78.
7. Chou, S.M. (1979) Pathognomy of intraneuronal inclusions in ALS. In: Tsubaki, T. and Toyokura, Y. (Eds.), Amyotrophic Lateral Sclerosis, pp. 135-176,.
8. Chou, S.M., J.D. Martin, J.A. Gutrecht and H.G. Thompson (1970) Axonal balloons in subacute motor neuron disease. J. Neuropathol. Exp. Neural., 29: 141.
9. Collard, J-F., F. Côté and J-P. Julien (1995) Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature, 375: 61-64.
10. Côté, F., J-F. Collard and J-P. Julien (1993) Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis. Cell, 73: 35-46.
11. Del Canto, M.C. and M.E. Gurney (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol., 145: 1271-1280.
12. Deng, H.-X., A. Hentati, J.A. Tainer et al. (1993) Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science, 261: 1047-1051.
13. Delisle, M.B. and S. Carpenter (1984) Neurofibrillary axonal swelling and amyotrophic lateral sclerosis. J. Neurol. Sci., 63: 241-250.
14. Dawson, V.L. (1995) Nitric oxide: role in neurotoxicity. Clin. Exp. Pharm. Physiol., 22: 305-308.
15. Dun, N.J., S.L. Dun and U. Forstermann (1994) Nitric oxide synthase immunoreactivity in rat pontine medullary neurons. Neuroscience, 59: 429-445.
16. Egberongbe, Y., I.S.M. Gentleman, P. Falkai, B. Bogerts, J.M. Polak and G.W. Roberts (1994) The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience, 59: 561-578.
17. Figlewicz, D.A., A. Krizus, M.G. Martinoli, V. Meininger, M. Dib, G.A. Rouleau and J.-P. Julien. (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet., 3: 1757-1761.
18. Figlewicz, D.A., G.A. Rouleau, A. Krizus and J.-P. Julien (1993) Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene. Gene, 132: 297-300.
19. Garthwaite, J. (1991) Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci., 14: 60-67.
20. Geisler, N. and K. Weber (1981) Self assembly in vitro of the 68,000 MW component of the mammalian neurofilament triplet protein into intermediate sized filament. J. Mol. Biol., 151: 565-571.
21. Hirano, A., H. Donnenfeld, S. Sasaki and I. Nakano (1984) Fine structural observation of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 43: 461-470.
22. Hirokawa, N. (1991) Molecular architecture and dynamics of the neuronal cytoskeleton. In: Burgoyne, R.D. (Ed.), The Neuronal Cytoskeleton. Wiley-Liss, New York, NY, pp. 5-74.
23. Hughes, J.T. and D. Jerrome (1971) Ultrastructure of anterior horn motor neurons in the Hirano-Kurland-Sayre type of combined neurological system degeneration. J. Neurol. Sci., 13: 389-399.
24. Inoue, K. and A. Hirano (1979) Early pathological changes of amyotrophic lateral sclerosis. Autopsy findings of a case of 10 month's duration. Neurol. Med. (Tokyo), 18: 136-144.
25. Ischiropoulos, H., L. Zhu, J. Chen, M. Tsai, J.C. Martin, C.D. Smith and J.S. Beckman (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys., 298: 431-437.
26. Julien, J.-P., L. Beaudet, I. Tretjakoff and A. Peterson (1990) Neurofilament gene expression in transgenic mice. J. Physiol., 84: 50-52.
27. Julien, J.-P. and W.E. Mushynski (1983) The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments. J. Biol. Chem., 258: 4019-4025.
28. Kondo, A., T. Iwaki, J. Tateishi, K. Kirimoto, T. Morimoto and I. Oomura (1986) Accumulation of neurofilaments in a sporadic amyotrophic lateral sclerosis. Jpn. J. Psychiatr. Neurol., 40: 677-684.
29. Kusaka, H. and A. Hirano (1985) Fine structure of anterior horns in patients without amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 44: 430-438.
30. Lee, M.K., J.R. Marszalek and D.W. Cleveland (1994) A mutant neurofilament subunit causes massive, selective motor neuron death: Implication for the pathogenesis of human motor neuron disease. Neuron, 13: 975-988.
31. Leigh, P.N., B.H. Anderton, A. Dodson, J.M. Gallo, M. Swash and D. Power (1992) Ubiquitin deposits in anterior horn cells in motor neuron disease. Neurosci. Lett., 93: 197-203.
32. Leigh, P.N., A. Dodson, M. Swash and J.-P. Brion (1991) Cytoskeletal abnormalities in motor neuron disease. Adv. Neurol., 56: 115-125.
33. Lennox, G., J. Lowe, K., Morrell et al. (1988) Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseases. Neurosci Lett., 24: 211-217.
34. Low, J., A. Blanchard, K. Morrell et al. (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J. Pathol., 155: 9-15.
35. Manetto, V., N.H. Sternberger, G. Perry, L.A. Sternberger and P. Gambetti (1988) Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol., 47; 642-653.
36. Martin, B.L., D. Wu, S. Jakes and D.J. Graves (1990) Chemical influences on the specificity of tyrosine phosphorylation. J. Biol. Chem., 265: 7108-7111.
37. Mathieu, J.F., D. Ma, L. Descarries, A. Vallee, A. Parent, J.-P. Julien and G. Doucet (1995) CNS distribution and overexpression of neurofilament light proteins (NF-L) in mice transgenic for the human NF-L: aberrant accumulation in thalamic perikarya. Exp. Neurol., 132: 134-146.
38. Munoz, D.G., C. Greene, D.P. Perl and D.J. Selkoe (1988) Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J. Neuropathol. Exp. Neurol., 47: 9-18.
39. Murayama, S., H. Mori, Y. Ihara, T.W. Bouldin, K. Suzuki and T. Tomonaga (1990) Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis. Ann. Neurol., 27: 137-148.
40. Nishiyama, K, S. Murayama, J. Shimizu, Y. Ohya et al. (1995) Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study. Acta Neuropathol., 89: 471-474.
41. Nixon, R.A. (1993) The regulation of neurofilament protein dynamics by phosphorylation: clue to neurofibrillary pathobiology. Brain Pathol., 3: 29-38.
42. Pardo, C.A., Z. Xu, D.R. Borchelt, D.L. Price, S.S. Sisodia and D.W. Cleveland (1995) Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Neurobiology, 92: 954-958.
43. Pasquaolotto, B.A., B.T. Hope and S.R. Vincent (1991) Citrulline in the rat brain: immunohistochemistry and coexistence with NADPH-diaphorase. Neurosci. Lett., 128: 155-160.
44. Perry, G., D. Stewart, R. Friedman, V. Manetto, L. Autilio-Gambetti and P. Gambetti (1987) Filaments of Pick's bodies contain altered cytoskeletal elements. Am. J. Pathol., 127: 559-568.
45. Rosen, D.R., T. Siddique, D. Patterson, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362: 59-62.
46. Saito, S., G.J. Kidd, B.D. Trapp, T.M. Dawson, D.S. Bredt, D.A. Wilson, R.J. Traystman, S.H. Snyder and D.F. Hanley (1994) Rat spinal cord neurons contain nitric oxide synthase. Neuroscience, 59: 447-56.
47. Satoh, K., R. Arai, K. Ikemoto, M. Narita, T. Nagai, H. Ohshima and K. Kitahama (1995) Distribution of nitric oxide synthase in the central nervous system of Macaca fuscata: subcortical regions. Neuroscience, 66: 685-696.
48. Schochet Jr., S.S., J.M. Hardman, P.P. Ladewig and K.M. Earle (1969) Intraneuronal conglomerates in sporadic motor neuron disease. Arch. Neurol., 20: 548-553.
49. Shibata, N., A. Hirano, M. Kobayashi, A Ikemoto, T. Umahara and K. Asayama (1994) CuZn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci. Lett., 179: 149-152.
50. Shibata, N., M. Hirano and K. Kobayashi (1993) Immunohistochemical demonstration of Cu/Zn superoxide dismutase in the spinal cord of patients with familial amyotrophic lateral sclerosis. Acta Histochem. Cytochem., 26: 619-621.
51. Siddique, T., D.A. Figelewicz, M.A. Percak-Vance et al. (1991) Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N. Engl. J. Med., 324: 1381-1384.
52. Sobue, G., Y. Hashizume, T. Yasuda, E. Mukai, T. Kumagai, T. Mitsuma and J.Q. Trojanowski (1990) Phosphorylated high moledcular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol., 79: 402-408.
53. Southam, E. and J. Garthwaite (1993) The nitric oxide-cyclic GMP signalling. Neuropharmacology, 32: 1267-1277.
54. Sternberger, L.A. and N.H. Sternberger (1983) Monoclonal antibodies distinguish phosphorylated and nonphosphorylated neurofilaments in situ. Proc. Natl. Acad. Sci. USA, 80: 6126-6130.
55. Troost, D., P.A.E. Sillevis Smitt, J.M.B.V. de long and D.F. Swaab (1992) Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis. Acta Neuropathol. 84: 664-673.
56. Wong, P.C., C.A. Pardo, D.R. Borchelt, M.K. Lee, N.G. Copeland, N.A. Jemkins, S.S. Sisodia, D.W. Cleveland and D.L. Price (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron, 14: 1105-1116.
57. Wu, W. and L. Li (1993) Inhibition of nitric oxide synthase reduces motor neuron death due to spinal root avulsion. Neurosci. Lett., 153: 121-124.
58. Yu, W.-H.A. (1994) Nitric oxide synthase in motor neurons after axotomy. J. Histochem. Cytochem., 42: 451-457.
59. Xu, Z., L. Cork, J.W. Griffin and D.W. Cleveland (1993). Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell, 73: 23-33.